Liberate

(redirected from NCI)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms, Wikipedia.

Liberate

(Liberate Technologies, San Mateo, CA) A software company that specialized in the information appliance field. Formerly Network Computer, Inc. (NCI), a spin-off from Oracle in 1996, it changed its name in 1999. The company initially promoted the NC Reference Profile specification, later turned over to The Open Group. Liberate provided client and server software for satellite, cable, telco, ISP and corporations to deliver thin computing services. In 2005 the company declared bankruptcy and sold its North American assets to Cox Communications and Comcast Corporation. See network computer.
References in periodicals archive ?
To address the interest in assuring that research resources are accessible, NCI requires applicants who respond to this RFA to submit a plan (1) for sharing the unique research resources generated through the grant; and (2) addressing how they will exercise IP rights, should any be generated through this grant, while making such research resources available to the broader scientific community.
At the meeting, NCI officials outlined a number of measures to help maintain the accuracy of NSABP data in the future.
PCC and NCI believe in a common vision of delivering a simple and affordable service through information appliances to the growing number of Asian consumers that want to become part of the on-line community.
NCI officials noted that the Pittsburgh staff might have discovered the faked data much earlier had they adopted a more rigorous audit schedule.
NCI is a leading provider of information technology services and solutions to U.
Collaboration with NCI-funded centers may be possible, as in the NCI Network for Translational Research in Optical Imaging (http://grants.
Under the purchasing arrangement, NCI has agreed to supply Tri-Steel components and materials for its own residential metal homes and certain of NCI's commercial and industrial metal building products.
But NCI "expressed concern that it would not be possible to accrue enough subjects to achieve the study's objectives if the risk of breast cancer was increased," testified Carl C.
The NCI and the Radiation Research Program (RRP) anticipate making up to three 5-year grant awards in fiscal year 2002.
Tamoxifen certainly is not miracle cure" or without risks, said NCI Director Samuel Broder at a press briefing in Bethesda, Md.